Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Growing Potential: mAb Production With Fibra-Cel

Published 22 May 2015 | By Eppendorf

The market for monoclonal antibodies continues to grow steadily, but there are still bottlenecks in the development of new products, including long development times mostly due to R&D. Advanced bioprocess equipment that meets the specific demands of mAb-producing hybridoma can accelerate design and production, and reduce overall development costs along the way.

Available Downloads

Growing Potential: mAb Production With Fibra-Cel